Compass Biotechnologies Inc. | Balance Sheet
Fiscal year is February-January. All values USD Thousands.
2011
2012
2015
2016
Cash & Short Term Investments
40.10
3.40
-
-
Total Accounts Receivable
45.10
48.50
-
-
Other Current Assets
225.00
11.70
-
-
Total Current Assets
310.20
63.50
-
-
Net Property, Plant & Equipment
0.70
0.30
-
-
Long-Term Note Receivable
10.20
10.20
-
-
Intangible Assets
695.10
550.20
-
-
Total Assets
1,016.20
624.20
-
-
ST Debt & Current Portion LT Debt
13.50
171.70
162.20
195.00
Accounts Payable
685.70
459.10
-
-
Other Current Liabilities
0.00
0.00
41.60
164.60
Total Current Liabilities
699.20
630.80
203.80
359.50
Total Liabilities
699.20
630.80
203.80
359.50
Common Equity (Total)
317.00
6.60
203.80
359.60
Total Shareholders' Equity
317.00
6.60
203.80
359.50
Total Equity
317.00
6.60
203.80
359.50
Liabilities & Shareholders' Equity
1,016.20
624.20
-
-
Preferred Stock (Carrying Value)
-
-
0.10
0.10
About Compass Biotechnologies
View Profile
